Change Makers: Richard Francis on the Pillars of Innovation 🔗 Access full article via Medscape NeurologyOne in every 13 prescriptions in the US is a generic from Teva. Now, CEO Richard Francis is focusing on drug development, delivering better medications faster. Medscape Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
